http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3911299-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c965b76827e500120c872ebf22a51655
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-555
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-282
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0009
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36002
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-00
filingDate 2020-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a3dc19e58b41860b7dc3c47c931c121
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_601929178564f1ea4c1d2cb56b7ed3ea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d6ac39f5a60920d8c602efca5fe91fb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f223e0344a06cf594f000487a6456a45
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0fd8bce44f9e95a520b370aa752d4506
publicationDate 2021-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-3911299-A1
titleOfInvention Treating gastric cancer using ttfields combined with xelox or folfox
abstract Methods of treating gastric cancer and reducing the viability of gastric cancer cells by administering folinic acid, fluorouracil, and oxaliplatin to a subject, and applying an alternating electric field to a target region of the subject are provided. In some instances, chemotherapy such as XELOX, FOLFOX and individual components thereof are administered to a subject followed by applying an alternating electric field to the subject.
priorityDate 2019-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415828867
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ5R1W0
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID397854
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454083818
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID11747
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135402009
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399572
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504969
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60953
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454411087
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID310
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP17153
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505489
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP81287
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ4R4H7
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415133005
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID281626
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6857599
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3385
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136123990
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP08758
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504160
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID137231040
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID132101
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP70075
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399412
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID161821941
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID337132
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25673
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399573
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP14668
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP48036
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID308
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226422204
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID11750
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135403648

Total number of triples: 63.